<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Osteopore on Bioecon</title><link>https://en.bioecon.ru/companies/osteopore/</link><description>Recent content in Osteopore on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Wed, 22 Jul 2026 21:08:41 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/osteopore/index.xml" rel="self" type="application/rss+xml"/><item><title>Bio-printing filaments (medical)</title><link>https://en.bioecon.ru/technology/bio-printing-filaments-medical/</link><pubDate>Wed, 22 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/bio-printing-filaments-medical/</guid><description>Bio-printing filaments (medical) are bioresorbable polymer materials extruded into filament or fiber form for 3D-printed medical devices that dissolve in the body as natural tissue regrows: Singapore&amp;rsquo;s Osteopore 3D-prints polycaprolactone-tricalcium-phosphate bone scaffolds, clinically used for critical-sized bone defects and now expanding into China. Germany&amp;rsquo;s Evonik and the Netherlands&amp;rsquo; Corbion supply FDA-approved, GMP-grade bioresorbable polymer feedstock (RESOMER and PURASORB) to device makers, while South Carolina&amp;rsquo;s Poly-Med vertically integrates polymer synthesis, filament extrusion and finished absorbable-device manufacturing under one roof.</description></item></channel></rss>